BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 8638614)

  • 1. Multiple myeloma presenting as plasmacytoma of the base of the skull.
    Alegre A; Tomás JF; Pinilla I; Gil-Fernández JJ; Fernández-Rañada JM
    Am J Hematol; 1996 May; 52(1):60-1. PubMed ID: 8638614
    [No Abstract]   [Full Text] [Related]  

  • 2. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple myeloma and destruction of the sella turcica].
    Delgado Lamas JL; Vázquez Villegas V; Galván Villegas F
    Sangre (Barc); 1990 Jun; 35(3):237-8. PubMed ID: 2396172
    [No Abstract]   [Full Text] [Related]  

  • 4. Cranial nerve palsy in multiple myeloma and solitary plasmacytoma.
    Kashyap R; Kumar R; Kumar S
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):251-5. PubMed ID: 21114773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ptosis and ophthalmoplegia as predominant signs of multiple myeloma].
    Roever AC; Rickes S; Flath B; Possinger K
    Dtsch Med Wochenschr; 2004 Feb; 129(9):434-6. PubMed ID: 14970915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
    Mellqvist UH; Lenhoff S; Johnsen HE; Hjorth M; Holmberg E; Juliusson G; Tangen JM; Westin J;
    Cancer; 2008 Jan; 112(1):129-35. PubMed ID: 17973267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
    Lokhorst HM; Sonneveld P; Cornelissen JJ; Joosten P; van Marwijk Kooy M; Meinema J; Nieuwenhuis HK; van Oers MH; Richel DJ; Segeren CN; Veth G; Verdonck LF; Wijermans PW
    Bone Marrow Transplant; 1999 Feb; 23(4):317-22. PubMed ID: 10100574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in the treatment of hematological malignancies. V. Therapy of multiple myeloma].
    Imamura Y
    Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):809-13. PubMed ID: 2677178
    [No Abstract]   [Full Text] [Related]  

  • 10. Oligoclonal reconstitution masquerading as myeloma relapse.
    Chim CS; Chan EY
    Ann Hematol; 2013 Jun; 92(6):847-8. PubMed ID: 23150202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrasellar solitary plasmacytoma terminating in multiple myeloma: a report of a case including electron microscopical study.
    Urbanski SJ; Bilbao JM; Horvath E; Kovacs K; So W; Ward JV
    Surg Neurol; 1980 Sep; 14(3):233-6. PubMed ID: 7001658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural effusion as the first sign of multiple myeloma.
    Uskül BT; Türker H; Emre Turan F; Unal Bayraktar O; Melikoğlu A; Tahaoğlu C; Oz B
    Tuberk Toraks; 2008; 56(4):439-42. PubMed ID: 19123081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Giant plasmacytoma of the skull which appeared in the clinical course of multiple myeloma--a case report].
    Sato M; Kanai N; Yamamoto S; Take H; Kuyama J; Shiraki T; Ozaki M; Kanayama Y; Hayakawa T
    No To Shinkei; 1993 Aug; 45(8):753-7. PubMed ID: 8217400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloma presenting during pregnancy.
    Smith D; Stevens J; Quinn J; Cavenagh J; Ingram W; Yong K
    Hematol Oncol; 2014 Mar; 32(1):52-5. PubMed ID: 23996410
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive myelomatous ascites responsive to VAD chemotherapy and autologous stem cell transplantation.
    Alegre A; Martínez-Chamorro C; Fernández-Rañada JM
    Bone Marrow Transplant; 1999 Aug; 24(3):343-4. PubMed ID: 10455378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic cutaneous plasmacytoma presenting as a perianal giant mass.
    Alvarez-Twose I; Vano-Galvan S; Calvo-Villas JM; Carreter E; Piqué E; Palacios S
    Dermatol Online J; 2008 Sep; 14(9):17. PubMed ID: 19061599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulbar palsy in multiple myeloma.
    Chim CS; Ooi GC
    Haematologica; 2005 Dec; 90(12 Suppl):ECR42. PubMed ID: 16464757
    [No Abstract]   [Full Text] [Related]  

  • 20. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
    van Rhee F
    Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.